75. Cushing disease Clinical trials / Disease details

Clinical trials : 205 / Drugs : 176 - (DrugBank : 45) / Drug target genes : 61 - Drug target pathways : 127

25 trials found

diseases per page:

Showing 1 to 10 of 25 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-001522-25-IT (EUCTR)	20/01/2020	28/04/2020	A study of osilodrostat in children and adolescents with Cushing's disease	A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmac ...	Cushing's disease MedDRA version: 20.0;Level: LLT;Classification code 10011651;Term: Cushing's disea ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: OSILODROSTAT Product Name: osil ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2	United States;Slovenia;Spain;Belgium;Bulgaria;United Kingdom;Italy
2	EUCTR2017-002840-34-NL (EUCTR)	14/11/2019	31/07/2019	Roll-over study to assess long-term safety in patients with endogenous Cushing’s syndrome who have c ...	An open-label, multi-center, roll-over study to assess long-term safety in patients with endogenous ...	Cushing's syndrome MedDRA version: 20.0;Level: PT;Classification code 10011652;Term: Cushing's syndr ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: osilodrostat Product Name: osil ...	Recordati AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 2	Portugal;United States;Spain;Costa Rica;Thailand;Turkey;Austria;Russian Federation;Italy;India;Franc ...
3	EUCTR2018-001522-25-ES (EUCTR)	02/10/2019	26/07/2019	A study of osilodrostat in children and adolescents with Cushing's disease	A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmac ...	Cushing's disease MedDRA version: 20.0;Level: LLT;Classification code 10011651;Term: Cushing's disea ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: OSILODROSTAT Product Name: osil ...	Novartis Farmacéutica, S.A.	NULL	Not Recruiting			Female: yes Male: yes	12	Phase 2	United States;Slovenia;Belgium;Spain;Bulgaria;Italy;United Kingdom
4	EUCTR2017-002840-34-FR (EUCTR)	08/07/2019	14/06/2018	Roll-over study to assess long-term safety in patients with endogenous Cushing’s syndrome who have c ...	An open-label, multi-center, roll-over study to assess long-term safety in patients with endogenous ...	Cushing's syndrome MedDRA version: 20.0;Level: PT;Classification code 10011652;Term: Cushing's syndr ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: osilodrostat Product Name: osil ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;Portugal;Greece;Thailand;Spain;Costa Rica;Russian Federation;Colombia;Switzerland;Ital ...
5	EUCTR2018-001522-25-BG (EUCTR)	04/07/2019	26/03/2019	A study of osilodrostat in children and adolescents with Cushing's disease	A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmac ...	Cushing's disease MedDRA version: 20.0;Level: LLT;Classification code 10011651;Term: Cushing's disea ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: OSILODROSTAT Product Name: osil ...	Recordati AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2	United States;Slovenia;Spain;Belgium;Bulgaria;United Kingdom;Italy
6	EUCTR2017-002840-34-BG (EUCTR)	18/06/2019	07/09/2018	Roll-over study to assess long-term safety in patients with endogenous Cushing’s syndrome who have c ...	An open-label, multi-center, roll-over study to assess long-term safety in patients with endogenous ...	Cushing's syndrome MedDRA version: 20.0;Level: PT;Classification code 10011652;Term: Cushing's syndr ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: osilodrostat Product Name: osil ...	Recordati AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 2	United States;Portugal;Greece;Thailand;Costa Rica;Spain;Russian Federation;Colombia;Italy;Switzerlan ...
7	EUCTR2018-001522-25-BE (EUCTR)	05/06/2019	30/04/2019	A study of osilodrostat in children and adolescents with Cushing's disease	A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmac ...	Cushing's disease MedDRA version: 20.0;Level: LLT;Classification code 10011651;Term: Cushing's disea ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: OSILODROSTAT Product Name: osil ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2	United States;Slovenia;Spain;Belgium;Bulgaria;United Kingdom;Italy
8	EUCTR2018-001522-25-SI (EUCTR)	10/05/2019	16/10/2018	A study of osilodrostat in children and adolescents with Cushing's disease	A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmac ...	Cushing's disease MedDRA version: 20.0;Level: LLT;Classification code 10011651;Term: Cushing's disea ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: OSILODROSTAT Product Name: osil ...	Recordati AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2	United States;Slovenia;Spain;Belgium;Bulgaria;United Kingdom;Italy
9	EUCTR2018-001522-25-GB (EUCTR)	19/03/2019	27/09/2018	A study of osilodrostat in children and adolescents with Cushing's disease	A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmac ...	Cushing's disease MedDRA version: 20.0;Level: LLT;Classification code 10011651;Term: Cushing's disea ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: OSILODROSTAT Product Name: osil ...	Recordati AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2	United States;Slovenia;Spain;Belgium;Bulgaria;Italy;United Kingdom
10	EUCTR2017-002840-34-BE (EUCTR)	07/02/2019	16/11/2018	Roll-over study to assess long-term safety in patients with endogenous Cushing’s syndrome who have c ...	An open-label, multi-center, roll-over study to assess long-term safety in patients with endogenous ...	Cushing's syndrome MedDRA version: 20.0;Level: PT;Classification code 10011652;Term: Cushing's syndr ...	Product Name: osilodrostat 1mg Product Code: LCI699 INN or Proposed INN: osilodrostat Product Name: osil ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;Portugal;Greece;Thailand;Spain;Costa Rica;Russian Federation;Colombia;Switzerland;Ital ...

First Previous1 2 3Next Last